Resistant hypertension is associated with an increased cardiovascular risk compared to patients controlled on a similar multi-drug regimen

Weitzman D, Chodick G, Shalev V, Grossman C, Grossman E. Prevalence and factors associated with resistant hypertension in a large health maintenance organization in Israel. Hypertension 2014;64:501–7.

CAS  Article  Google Scholar 

Carey RM, Sakhuja S, Calhoun DA, Whelton PK, Muntner P. Prevalence of apparent treatment-resistant hypertension in the United States. Hypertension 2019;73:424–31.

CAS  Article  Google Scholar 

Spence JD. Controlling resistant hypertension. Stroke Vasc Neurol. 2018;3:69–75.

Article  Google Scholar 

Carey RM, Calhoun DA, Bakris GL, Brook RD, Daugherty SL, Dennison-Himmelfarb CR, et al. Resistant hypertension: Detection, evaluation, and management: A scientific statement from the American Heart Association. Hypertension 2018;72:e53–e90.

CAS  Article  Google Scholar 

Daugherty SL, Powers JD, Magid DJ, Tavel HM, Masoudi FA, Margolis KL, et al. Incidence and prognosis of resistant hypertension in hypertensive patients. Circulation 2012;125:1635–42.

Article  Google Scholar 

Shalev V, Chodick G, Goren I, Silber H, Kokia E, Heymann AD. The use of an automated patient registry to manage and monitor cardiovascular conditions and related outcomes in a large health organization. Int J Cardiol. 2011;152:345–9.

Article  Google Scholar 

Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr., et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003;42:1206–52.

CAS  Article  Google Scholar 

Irvin MR, Booth JN 3rd, Shimbo D, Lackland DT, Oparil S, Howard G, et al. Apparent treatment-resistant hypertension and risk for stroke, coronary heart disease, and all-cause mortality. J Am Soc Hypertens. 2014;8:405–13.

Article  Google Scholar 

Howard VJ, Tanner RM, Anderson A, Irvin MR, Calhoun DA, Lackland DT, et al. Apparent treatment-resistant hypertension among individuals with history of stroke or transient ischemic attack. Am J Med. 2015;128:707–714.

Article  Google Scholar 

Sim JJ, Bhandari SK, Shi J, Reynolds K, Calhoun DA, Kalantar-Zadeh K, et al. Comparative risk of renal, cardiovascular, and mortality outcomes in controlled, uncontrolled resistant, and nonresistant hypertension. Kidney Int. 2015;88:622–32.

Article  Google Scholar 

Bangalore S, Fayyad R, Laskey R, Demicco DA, Deedwania P, Kostis JB, et al. Prevalence, predictors, and outcomes in treatment-resistant hypertension in patients with coronary disease. Am J Med. 2014;127:71–81. e71.

Article  Google Scholar 

Fontil V, Bibbins-Domingo K, Nguyen OK, Guzman D, Goldman LE. Management of hypertension in primary care safety-net clinics in the United States: A comparison of community health centers and private physicians’ Offices. Health Serv Res. 2017;52:807–25.

Article  Google Scholar 

留言 (0)

沒有登入
gif